|
RAB6C expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.459600E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.822800E-03 |
| Normal-vs-Stage2 |
4.255800E-02 |
| Normal-vs-Stage3 |
5.235500E-04 |
| Normal-vs-Stage4 |
2.516100E-02 |
| Stage1-vs-Stage2 |
9.903000E-01 |
| Stage1-vs-Stage3 |
1.358960E-01 |
| Stage1-vs-Stage4 |
5.632000E-01 |
| Stage2-vs-Stage3 |
2.952400E-01 |
| Stage2-vs-Stage4 |
6.696400E-01 |
| Stage3-vs-Stage4 |
6.846600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.537640E-03 |
| Normal-vs-AfricanAmerican |
2.036700E-03 |
| Normal-vs-Asian |
6.461700E-02 |
| Caucasian-vs-AfricanAmerican |
1.338180E-01 |
| Caucasian-vs-Asian |
4.326200E-01 |
| AfricanAmerican-vs-Asian |
6.560400E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.302300E-03 |
| Normal-vs-Female |
2.683600E-03 |
| Male-vs-Female |
8.651000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.318100E-03 |
| Normal-vs-Age(41-60Yrs) |
5.581500E-04 |
| Normal-vs-Age(61-80Yrs) |
1.020030E-02 |
| Normal-vs-Age(81-100Yrs) |
2.878100E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.591000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.335400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.792200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.684200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.833800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.984000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
9.990600E-01 |
| Classical-VS-Follicular |
3.055600E-02 |
| Classical-VS-Other |
4.341000E-01 |
| Classical-VS-Normal |
2.136700E-03 |
| Tall-VS-Follicular |
1.097380E-01 |
| Tall-VS-Other |
5.355600E-01 |
| Tall-VS-Normal |
1.178440E-02 |
| Follicular-VS-Other |
6.870000E-02 |
| Follicular-VS-Normal |
3.139200E-01 |
| Other-VS-Normal |
1.367540E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.378830E-03 |
| Normal-vs-N1 |
1.196050E-02 |
| N0-vs-N1 |
8.055800E-01 |
|
|
